Ivermectin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ivermectin and what is the scope of patent protection?
Ivermectin
is the generic ingredient in four branded drugs marketed by Padagis Israel, Teva Pharms Usa, Zydus Lifesciences, Galderma Labs Lp, Taro, Arbor Pharms Llc, Edenbridge Pharms, and Merck Sharp Dohme, and is included in nine NDAs. There are twelve patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.Ivermectin has seventy-seven patent family members in twenty-eight countries.
There are five drug master file entries for ivermectin. Twenty suppliers are listed for this compound.
Summary for ivermectin
International Patents: | 77 |
US Patents: | 12 |
Tradenames: | 4 |
Applicants: | 8 |
NDAs: | 9 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 206 |
Patent Applications: | 7,396 |
Drug Prices: | Drug price trends for ivermectin |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ivermectin |
What excipients (inactive ingredients) are in ivermectin? | ivermectin excipients list |
DailyMed Link: | ivermectin at DailyMed |
Recent Clinical Trials for ivermectin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Public Health Laboratory Ivo de Carneri | Phase 2 |
National Public Health Institute of Liberia | Phase 2 |
Vector Borne & Neglected Tropical Disease Control Division, Ministry of Health, Uganda | Phase 3 |
Pharmacology for ivermectin
Drug Class | Antiparasitic Pediculicide |
Medical Subject Heading (MeSH) Categories for ivermectin
Anatomical Therapeutic Chemical (ATC) Classes for ivermectin
Paragraph IV (Patent) Challenges for IVERMECTIN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SKLICE | Lotion | ivermectin | 0.50% | 202736 | 1 | 2017-09-01 |
SOOLANTRA | Cream | ivermectin | 1% | 206255 | 1 | 2016-12-30 |
US Patents and Regulatory Information for ivermectin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galderma Labs Lp | SOOLANTRA | ivermectin | CREAM;TOPICAL | 206255-001 | Dec 19, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Galderma Labs Lp | SOOLANTRA | ivermectin | CREAM;TOPICAL | 206255-001 | Dec 19, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Galderma Labs Lp | SOOLANTRA | ivermectin | CREAM;TOPICAL | 206255-001 | Dec 19, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Taro | IVERMECTIN | ivermectin | LOTION;TOPICAL | 210720-001 | May 6, 2020 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Padagis Israel | IVERMECTIN | ivermectin | CREAM;TOPICAL | 210225-001 | Apr 13, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ivermectin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galderma Labs Lp | SOOLANTRA | ivermectin | CREAM;TOPICAL | 206255-001 | Dec 19, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Galderma Labs Lp | SOOLANTRA | ivermectin | CREAM;TOPICAL | 206255-001 | Dec 19, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Galderma Labs Lp | SOOLANTRA | ivermectin | CREAM;TOPICAL | 206255-001 | Dec 19, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Galderma Labs Lp | SOOLANTRA | ivermectin | CREAM;TOPICAL | 206255-001 | Dec 19, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Galderma Labs Lp | SOOLANTRA | ivermectin | CREAM;TOPICAL | 206255-001 | Dec 19, 2014 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ivermectin
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 6438466 | ⤷ Sign Up | |
Brazil | PI0410503 | uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição | ⤷ Sign Up |
Chile | 2016000009 | Tratamiento de rosacea papulopustular con ivermectina. | ⤷ Sign Up |
Poland | 378932 | Zastosowanie ivermectiny do leczenia schorzeń dermatologicznych (TOPICAL FORMULATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS) | ⤷ Sign Up |
Russian Federation | 2005136438 | ПРИМЕНЕНИЕ ИВЕРМЕКТИНА ДЛЯ ЛЕЧЕНИЯ ДЕРМАТОЛОГИЧЕСКИХ РАССТРОЙСТВ | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ivermectin
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1620113 | C 2015 036 | Romania | ⤷ Sign Up | PRODUCT NAME: IVERMECTINA; NATIONAL AUTHORISATION NUMBER: RO7674/2015/01, RO7674/2015/02, RO7674/2015/03, RO7674/2015/04, RO7674/2015/05; DATE OF NATIONAL AUTHORISATION: 20150526; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): MALTA MA117/01101; DATE OF FIRST AUTHORISATION IN EEA: 20150402 |
1620113 | CR 2015 00045 | Denmark | ⤷ Sign Up | PRODUCT NAME: LVERMECTIN (22,23-DIHYDROAVERMECTIN B1 A + 22,23-DIHYDROAVERMECTIN B1 B); NAT. REG. NO/DATE: 54123 20150422; FIRST REG. NO/DATE: MT MA 117/01101 20150402 |
1620113 | C300756 | Netherlands | ⤷ Sign Up | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN; NAT. REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MA117/01101 20150402 |
1620113 | PA2015033,C1620113 | Lithuania | ⤷ Sign Up | PRODUCT NAME: IVERMEKTINAS; NAT. REGISTRATION NO/DATE: LT/1/15/3726/001 - LT/1/15/3726/005 20150513; FIRST REGISTRATION: MA117/01101 20150402 |
1620113 | 15C0069 | France | ⤷ Sign Up | PRODUCT NAME: IVERMECTINE; NAT. REGISTRATION NO/DATE: NL 44511 20150721; FIRST REGISTRATION: MT - MA 117/01101 20150402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.